Bromantane upregulates expression of tyrosine hydroxylase — the rate-limiting enzyme in the biosynthesis of dopamine from L-tyrosine. This mechanism produces sustained enhancement of endogenous dopamine synthesis without direct receptor agonism, differentiating it from amphetamines and catecholamine releasers. TH upregulation is confirmed across striatal and limbic tissue in rodent models.

Grekhova et al., Bull Exp Biol Med; Kudrin et al., Eksp Klin Farmakol [4,5]

Alongside TH, Bromantane increases expression of aromatic L-amino acid decarboxylase (AAAD/DOPA decarboxylase) — the second enzyme in the dopamine biosynthesis pathway, converting L-DOPA to dopamine. Dual upregulation of both TH and AAAD creates a synergistic enhancement of the full dopamine synthesis cascade, producing measurable increases in dopamine turnover in freely moving rat dorsal striatum via microdialysis.

Grekhova et al., Bull Exp Biol Med [4]

Bromantane activates cAMP-dependent, calcium-dependent, and protein kinase C (PKC) intracellular signalling pathways. These cascades act as second messengers that instruct gene regulatory regions to upregulate TH and AAAD mRNA expression — providing the mechanistic link between Bromantane receptor engagement and sustained dopaminergic enzyme upregulation at the transcriptional level.

PureRawz research literature; preclinical CNS signalling studies

In addition to dopaminergic effects, Bromantane modulates serotonin system activity in preclinical models. Rodent studies document changes in serotonin and its metabolite 5-HIAA in discrete brain regions following Bromantane administration, with serotonergic effects observed at doses overlapping with dopaminergic activity — contributing to the compound's combined stimulant and anxiolytic research profile.

Kudrin et al., Eksp Klin Farmakol [5]

Classified as an actoprotector — a category of compounds that increase physical working capacity without stimulating oxygen demand or cardiovascular load — Bromantane delays performance decline during repeated or extreme physical tasks in rodent endurance models. This activity is mechanistically linked to dopaminergic upregulation and mitochondrial energy pathway modulation, producing sustained output without the rebound fatigue typical of classical stimulants.

Oliynyk & Bhanu Rekha, Biomol Ther 2013 [2]

In animal research under stress conditions, Bromantane demonstrated immunostimulatory effects including increased resistance to toxins and enhanced B-cell production in rat models. It also modulates the hypothalamic-pituitary-adrenal (HPA) axis, with research demonstrating reduced corticosteroid stress responses — providing a neuroimmune research dimension distinct from classical stimulant compounds.

Iezhitsa et al., Bull Exp Biol Med [3]; preclinical immunology literature